MediciNova, Inc. (MNOV) Social Stream

MediciNova, Inc. (MNOV): $2.40

-0.01 (-0.41%)

POWR Rating

Component Grades













Add MNOV to Watchlist
Sign Up

Industry: Biotech


of 459

in industry

Medicinova Inc (MNOV) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Medicinova Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 3 $27 $10 $16.5 $2.69 513.38%
2022-03-01 1 $27 $6 $14.333 $2.69 432.83%

Price Target Last Issued March 1, 2022

The Trend in the Analyst Price Target

Over the past 21 months, MNOV's average price target has gone down $3.99.

Over the past 46 weeks, MNOV's average upside potential has been 364.2%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 0 26.5 11 17.630 4.74 271.94%
2021-08-28 2 27.0 10 16.500 3.81 333.07%
2021-09-04 3 27.0 10 16.500 4.17 295.68%
2021-09-19 3 27.0 10 16.500 3.92 320.92%
2022-03-01 2 27.0 6 14.333 2.35 509.91%

MNOV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations

Over the past 30 weeks, MNOV's average broker recommendation rating improved by 1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Medicinova Inc's upside potential (average analyst target price relative to current price) is greater than 480.15% of them.
  • MNOV has a lower variance in analysts' estimates than -378.93% of all US stocks.
  • MNOV has a greater number of analysts covering the stock than 38.13% of all US stocks.
  • In terms of how Medicinova Inc fares relative to Healthcare stocks, note that its average analyst price target is higher than 126.47% of that group.

Stocks similar to Medicinova Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MIST, MIRM, and MGTA.

Is MNOV a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4581 seconds.